Monkey eyeing sampling platform

CREATE-NEO: Sandra López-Vergès, PhD
and the Panama Team


Sandra LopezDr. López-Vergès

Senior Researcher, Gorgas Memorial Institute and Associate Professor, Universidad de Panamá Expertise: Molecular epidemiology, cellular virology, and immunology of viral diseases

Email: slopez@gorgas.gob.pa

My research focuses on understanding the virological and immunological factors shaping the emergence of viruses and the severity of diseases associated with viral infection in humans. To answer these questions my research integrates clinical, virological, cellular, molecular and immunological approaches and a continued collaboration with researchers from other fields like medicine, epidemiology, entomology and statistics. The ultimate goal is to identify biomarkers of infection or disease severity that will be used to guide clinical management of patients, as well as to develop new effective treatments and vaccines.

Members of the López-Vergès group:

  • Yamilka Díaz (Biologist, investigator)
  • Josefrancisco Galué (Laboratory research assistant, project coordinator)
  • Yaneth Pitti (Laboratory research assistant)
  • Davis Beltrán (Medical Technologist, PhD Student Acharya Nagarjuna University in India)
  • Rita Corrales (Medical Technologist, laboratory research assistant)
  • Alejandra Valoy (Laboratory research assistant)
  • Madelaine Hernandez (Administrative project coordinator)

Publications:


Panama Team

 

 


CREATE-NEO members

The Centers for Research in Emerging Infectious Disease (CREID) is a coordinated network with centers in regions around the globe where emerging and re-emerging infectious disease outbreaks are likely to occur. Multidisciplinary teams of investigators will conduct pathogen/host surveillance, study pathogen transmission, pathogenesis and immunologic responses in the host, and will develop reagents and diagnostic assays for improved detection for important emerging pathogens and their vectors.


NIAID launched the CREID Network in 2020.This website is run by CREATE-NEO, a member of the CREID Network independent of NIH/NIAID.